The Board met today and approved the semester consolidated financial report dated June 30, 2020, which was drawn up according to the IAS/IFRS accounting principles.
“We are very satisfied with the results of the first half, which show an increase in both Revenues and EBITDA. This result proves the resilience capabilities of our Group in an extraordinary period of health emergency. GPI has operated continuously and diligently by reorganising its activities to ensure the utmost safety for collaborators, customers and suppliers. Our commitment has allowed us to continuously support the national health system – states Fausto Manzana, CEO and President of Gpi Group -. TThis pandemic has concretely demonstrated the significance of our work for the health of people and the contribution we can make to the sustainability of national health systems. Our path for development will continue with this awareness.”
On November 21 at the CIC Forum 2024, November 27 at the European Midcap, and December 3 at the Mid & Small in Milan
Innovation and technology for a new cell therapy supply chain.
A journey of transparent commitments, daily actions, and long-term vision